{"id":{"repo_id":"rockefeller","oai_identifier":"oai:digitalcommons.rockefeller.edu:student_theses_and_dissertations-1440"},"canonical_url":"https://search.dev.ndltd.org/etd/rockefeller/oai:digitalcommons.rockefeller.edu:student_theses_and_dissertations-1440","repository":{"repo_id":"rockefeller","name":"Rockefeller","base_url":"https://digitalcommons.rockefeller.edu/do/oai/"},"display":{"title":"Cell Type Specific Roles of Serotonin Receptor 4 in the Hippocampus and Neocortex in Emotion and Cognition","abstract":"<p>Anxiety and mood disorders are the most prevalent classes of mental disorders. However, current treatments for these debilitating diseases are limited due to their delayed onset of action and numerous side effects, emphasizing the need for faster acting and more efficacious therapies. Preclinical studies indicate a critical role for Serotonin Receptor 4 (5-HT<sub>4</sub>R, product of the Htr4 gene) in this direction as drugs that activate this receptor show fast-acting antidepressant-like properties. Unfortunately, 5-HT<sub>4</sub>R is widely expressed in the periphery, limiting its use as a direct therapeutic target due to various side effects. Understanding the cell type specific mechanisms of 5-HT<sub>4</sub>R function in the brain will facilitate the development of novel therapies. To dissect the function of 5-HT<sub>4</sub>R in genetically defined cell types of the hippocampus and neocortex, two regions highly implicated in emotive and cognitive function, I generated a novel Cre-dependent Htr4 knockout mouse line. Intriguingly, the loss of functional 5-HT<sub>4</sub>R specifically in the mature excitatory neurons of the hippocampus led to robust antidepressant-like behavioral, cellular and molecular responses. These phenotypes were accompanied by elevated innate anxiety levels and deficits in hippocampus-dependent memories. By slice electrophysiology, we showed that 5-HT<sub>4</sub>R was necessary for the proper excitability of dentate gyrus granule cells. To identify molecular adaptations underlying the observed changes in behavior and neuronal activity, I used the translating ribosome affinity purification (TRAP) approach combined with nextgeneration RNA sequencing to measure hippocampal region- and cell typespecific differential gene expression in the presence and absence of 5-HT<sub>4</sub>R. Analysis of these datasets revealed that the ventral and dorsal hippocampus underwent distinct molecular adaptations, and identified functionally relevant genes that may underlie these phenotypes and be potential therapeutic targets. My graduate work identified unique roles for hippocampal 5-HT<sub>4</sub>R in modulating mood, anxiety and memory. By regulating the excitability of individual neurons and relevant intracellular pathways, 5-HT<sub>4</sub>R mediates functionally distinct hippocampal circuits. Our findings suggest divergent molecular and functional roles for 5-HT<sub>4</sub>R along the dorsoventral axis of the hippocampus, and that specific cell type- or circuit-based strategies that target the 5-HT<sub>4</sub>R pathway may yield more effective antidepressant therapies.</p>","abstract_html":"&lt;p&gt;Anxiety and mood disorders are the most prevalent classes of mental disorders. However, current treatments for these debilitating diseases are limited due to their delayed onset of action and numerous side effects, emphasizing the need for faster acting and more efficacious therapies. Preclinical studies indicate a critical role for Serotonin Receptor 4 (5-HT&lt;sub&gt;4&lt;/sub&gt;R, product of the Htr4 gene) in this direction as drugs that activate this receptor show fast-acting antidepressant-like properties. Unfortunately, 5-HT&lt;sub&gt;4&lt;/sub&gt;R is widely expressed in the periphery, limiting its use as a direct therapeutic target due to various side effects. Understanding the cell type specific mechanisms of 5-HT&lt;sub&gt;4&lt;/sub&gt;R function in the brain will facilitate the development of novel therapies. To dissect the function of 5-HT&lt;sub&gt;4&lt;/sub&gt;R in genetically defined cell types of the hippocampus and neocortex, two regions highly implicated in emotive and cognitive function, I generated a novel Cre-dependent Htr4 knockout mouse line. Intriguingly, the loss of functional 5-HT&lt;sub&gt;4&lt;/sub&gt;R specifically in the mature excitatory neurons of the hippocampus led to robust antidepressant-like behavioral, cellular and molecular responses. These phenotypes were accompanied by elevated innate anxiety levels and deficits in hippocampus-dependent memories. By slice electrophysiology, we showed that 5-HT&lt;sub&gt;4&lt;/sub&gt;R was necessary for the proper excitability of dentate gyrus granule cells. To identify molecular adaptations underlying the observed changes in behavior and neuronal activity, I used the translating ribosome affinity purification (TRAP) approach combined with nextgeneration RNA sequencing to measure hippocampal region- and cell typespecific differential gene expression in the presence and absence of 5-HT&lt;sub&gt;4&lt;/sub&gt;R. Analysis of these datasets revealed that the ventral and dorsal hippocampus underwent distinct molecular adaptations, and identified functionally relevant genes that may underlie these phenotypes and be potential therapeutic targets. My graduate work identified unique roles for hippocampal 5-HT&lt;sub&gt;4&lt;/sub&gt;R in modulating mood, anxiety and memory. By regulating the excitability of individual neurons and relevant intracellular pathways, 5-HT&lt;sub&gt;4&lt;/sub&gt;R mediates functionally distinct hippocampal circuits. Our findings suggest divergent molecular and functional roles for 5-HT&lt;sub&gt;4&lt;/sub&gt;R along the dorsoventral axis of the hippocampus, and that specific cell type- or circuit-based strategies that target the 5-HT&lt;sub&gt;4&lt;/sub&gt;R pathway may yield more effective antidepressant therapies.&lt;/p&gt;","abstract_has_math":false,"creators":["Karayol, Remzi"],"institution":null,"degree_name":"Doctor of Philosophy (PhD)","degree_level":"Thesis","degree_discipline":null,"degree_department":null,"school":null,"contributors":["Nathaniel Heintz"],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2018,"date_issued":"2018-01-01T08:00:00Z","date_published":"2018-01-01T08:00:00Z","updated_at":"2026-07-24T04:11:45Z","subjects":["5-HT4 receptor","hippocampus","antidepressant therapies","excitatory neurons","anxiety and memory","gene expression profiling","Life Sciences"],"languages":[],"rights":[],"rights_urls":[],"identifier_entries":[]},"links":{"outbound_url":"https://digitalcommons.rockefeller.edu/student_theses_and_dissertations/430","outbound_label":"Repository record","outbound_source":"dc:identifier"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Nathaniel Heintz"]},{"key":"dc:creator","label":"Author","values":["Karayol, Remzi"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"thesis:degree_level","label":"Degree Level","values":["Thesis"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Doctor of Philosophy (PhD)"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["5-HT4 receptor","hippocampus","antidepressant therapies","excitatory neurons","anxiety and memory","gene expression profiling","Life Sciences"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["https://digitalcommons.rockefeller.edu/student_theses_and_dissertations/430"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["<p>Anxiety and mood disorders are the most prevalent classes of mental disorders. However, current treatments for these debilitating diseases are limited due to their delayed onset of action and numerous side effects, emphasizing the need for faster acting and more efficacious therapies. Preclinical studies indicate a critical role for Serotonin Receptor 4 (5-HT<sub>4</sub>R, product of the Htr4 gene) in this direction as drugs that activate this receptor show fast-acting antidepressant-like properties. Unfortunately, 5-HT<sub>4</sub>R is widely expressed in the periphery, limiting its use as a direct therapeutic target due to various side effects. Understanding the cell type specific mechanisms of 5-HT<sub>4</sub>R function in the brain will facilitate the development of novel therapies. To dissect the function of 5-HT<sub>4</sub>R in genetically defined cell types of the hippocampus and neocortex, two regions highly implicated in emotive and cognitive function, I generated a novel Cre-dependent Htr4 knockout mouse line. Intriguingly, the loss of functional 5-HT<sub>4</sub>R specifically in the mature excitatory neurons of the hippocampus led to robust antidepressant-like behavioral, cellular and molecular responses. These phenotypes were accompanied by elevated innate anxiety levels and deficits in hippocampus-dependent memories. By slice electrophysiology, we showed that 5-HT<sub>4</sub>R was necessary for the proper excitability of dentate gyrus granule cells. To identify molecular adaptations underlying the observed changes in behavior and neuronal activity, I used the translating ribosome affinity purification (TRAP) approach combined with nextgeneration RNA sequencing to measure hippocampal region- and cell typespecific differential gene expression in the presence and absence of 5-HT<sub>4</sub>R. Analysis of these datasets revealed that the ventral and dorsal hippocampus underwent distinct molecular adaptations, and identified functionally relevant genes that may underlie these phenotypes and be potential therapeutic targets. My graduate work identified unique roles for hippocampal 5-HT<sub>4</sub>R in modulating mood, anxiety and memory. By regulating the excitability of individual neurons and relevant intracellular pathways, 5-HT<sub>4</sub>R mediates functionally distinct hippocampal circuits. Our findings suggest divergent molecular and functional roles for 5-HT<sub>4</sub>R along the dorsoventral axis of the hippocampus, and that specific cell type- or circuit-based strategies that target the 5-HT<sub>4</sub>R pathway may yield more effective antidepressant therapies.</p>"]},{"key":"dc:title","label":"Title","values":["Cell Type Specific Roles of Serotonin Receptor 4 in the Hippocampus and Neocortex in Emotion and Cognition"]}]}],"canonical_facts":{"dc:contributor":["Nathaniel Heintz"],"dc:creator":["Karayol, Remzi"],"dc:description.abstract":["<p>Anxiety and mood disorders are the most prevalent classes of mental disorders. However, current treatments for these debilitating diseases are limited due to their delayed onset of action and numerous side effects, emphasizing the need for faster acting and more efficacious therapies. Preclinical studies indicate a critical role for Serotonin Receptor 4 (5-HT<sub>4</sub>R, product of the Htr4 gene) in this direction as drugs that activate this receptor show fast-acting antidepressant-like properties. Unfortunately, 5-HT<sub>4</sub>R is widely expressed in the periphery, limiting its use as a direct therapeutic target due to various side effects. Understanding the cell type specific mechanisms of 5-HT<sub>4</sub>R function in the brain will facilitate the development of novel therapies. To dissect the function of 5-HT<sub>4</sub>R in genetically defined cell types of the hippocampus and neocortex, two regions highly implicated in emotive and cognitive function, I generated a novel Cre-dependent Htr4 knockout mouse line. Intriguingly, the loss of functional 5-HT<sub>4</sub>R specifically in the mature excitatory neurons of the hippocampus led to robust antidepressant-like behavioral, cellular and molecular responses. These phenotypes were accompanied by elevated innate anxiety levels and deficits in hippocampus-dependent memories. By slice electrophysiology, we showed that 5-HT<sub>4</sub>R was necessary for the proper excitability of dentate gyrus granule cells. To identify molecular adaptations underlying the observed changes in behavior and neuronal activity, I used the translating ribosome affinity purification (TRAP) approach combined with nextgeneration RNA sequencing to measure hippocampal region- and cell typespecific differential gene expression in the presence and absence of 5-HT<sub>4</sub>R. Analysis of these datasets revealed that the ventral and dorsal hippocampus underwent distinct molecular adaptations, and identified functionally relevant genes that may underlie these phenotypes and be potential therapeutic targets. My graduate work identified unique roles for hippocampal 5-HT<sub>4</sub>R in modulating mood, anxiety and memory. By regulating the excitability of individual neurons and relevant intracellular pathways, 5-HT<sub>4</sub>R mediates functionally distinct hippocampal circuits. Our findings suggest divergent molecular and functional roles for 5-HT<sub>4</sub>R along the dorsoventral axis of the hippocampus, and that specific cell type- or circuit-based strategies that target the 5-HT<sub>4</sub>R pathway may yield more effective antidepressant therapies.</p>"],"dc:identifier":["https://digitalcommons.rockefeller.edu/student_theses_and_dissertations/430"],"dc:subject":["5-HT4 receptor","hippocampus","antidepressant therapies","excitatory neurons","anxiety and memory","gene expression profiling","Life Sciences"],"dc:title":["Cell Type Specific Roles of Serotonin Receptor 4 in the Hippocampus and Neocortex in Emotion and Cognition"],"thesis:degree_level":["Thesis"],"thesis:degree_name":["Doctor of Philosophy (PhD)"]},"updated_at":"2026-07-24T04:11:45Z"}